RXRX RECURSION PHARMACEUTICALS IN
FollowCL A (common), issuer CIK 1601830
Filings received so far for Q3 2026: 11 13F filers report a position in RXRX shares at 2026-09-30. The quarter is not complete: its 13F deadline is 2026-11-14, and the counts grow as filings arrive.
13D and 13G filers
No 13D or 13G on this security in the data. Structured 13D/G data starts 2024-12-18.
Insider trades
| Owner | Date | Shares | Price | Filing |
|---|---|---|---|---|
| Borgeson Blakedirector | 2026-10-06 | -50,000 S | $4.84 | Form 4 |
| HERSHBERG ROBERTdirector | 2026-10-06 | -25,000 S | $5 | Form 4 |
| HERSHBERG ROBERTdirector | 2026-10-06 | +25,000 M | $2.22 | Form 4 |
13F holders, Q3 2026
Filers in the available 13F reports with a share position at 2026-09-30, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.
| Holder | Shares | Value | % of portfolio | Change | Source |
|---|---|---|---|---|---|
| Green Alpha Advisors, LLC | 239,404 | $989K | 0.67% | +91,860 | 13F-HRTimeline |
| Whalen Wealth Management Inc. | 48,282 | $199K | 0.09% | new | 13F-HRTimeline |
| Wedmont Private Capital | 18,943 | $74.8K | <0.01% | 0 | 13F-HRTimeline |
| Farther Finance Advisors, LLC | 12,978 | $53.6K | <0.01% | -763 | 13F-HRTimeline |
| CoreCap Advisors, LLC | 11,820 | $48.8K | <0.01% | 0 | 13F-HRTimeline |
| Quintet Private Bank (Europe) S.A. | 8,620 | $35.6K | <0.01% | 0 | 13F-HRTimeline |
| GAMMA Investing LLC | 4,209 | $17.4K | <0.01% | +3,787 | 13F-HRTimeline |
| MassMutual Private Wealth & Trust, FSB | 3,853 | $15.9K | <0.01% | 0 | 13F-HRTimeline |
| Roxbury Financial LLC | 1,000 | $4.13K | <0.01% | new | 13F-HRTimeline |
| HARBOR INVESTMENT ADVISORY, LLC | 208 | $859 | <0.01% | new | 13F-HRTimeline |
| Marquette Asset Management, LLC | 179 | $740 | <0.01% | new | 13F-HRTimeline |
Events
Borgeson Blake sold 50,000 RXRX shares on 2026-10-06, Form 4 filed 2026-10-07. 0001601830-26-000120
Accepted , ingestedHERSHBERG ROBERT reported transactions in RXRX shares with no net change in a Form 4 filed 2026-10-07. 0001601830-26-000119
Accepted , ingested